Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-13

Clinical Trial Update: A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures [Phase 4]

View source ↗

Summary

Phase 4 clinical study evaluating zonisamide as a first add-on therapy for epileptic seizures. The study is currently recruiting at Affiliated Hospital of Nanto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zonegran (zonisamide)

Snippet

Sponsor: Affiliated Hospital of Nantong University | Conditions: Epilepsies, Partial, Epilepsy, Tonic-Clonic | Phase 4 | Status: RECRUITING